Two clinical gastrointestinal experts are the newest members of the clinical advisory board at Tranzyme Pharma.

Raj Goyal is Mallinckrodt Professor of Medicine at the Harvard Medical School.

Henry P. Parkman is a professor of medicine at Temple University.

Both are MDs.

Tranzyme is developing drug candidates from its medicinal chemistry platform to treat certain diseases of the GI tract.